Science Explorer Back to mapMap
Institution · Barts Health NHS Trust

Most cited papers from Barts Health NHS Trust

What are the most cited papers from Barts Health NHS Trust?

The most cited paper from Barts Health NHS Trust is "The mutational constraint spectrum quantified from variation in 141,456 humans" (Konrad J. Karczewski et al., 2020), with 10,422 citations. Next come "COVID-19: consider cytokine storm syndromes and immunosuppression" (10,244) and "Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing" (7,931).

Showing 50 of 59 papers. Every paper with more than 1,526 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The mutational constraint spectrum quantified from variation in 141,456 humans Konrad J. Karczewski et al. · Nature Open access177 authors 27 May 2020 10,422
2 COVID-19: consider cytokine storm syndromes and immunosuppression Puja Mehta, Daniel Francis McAuley, Michael Brown et al. · The Lancet Open access Mar 2020 10,244
3 Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing Marco Gerlinger et al. · New England Journal of Medicine Open access 7 Mar 2012 7,931
4 Inflammation and cancer: back to Virchow? Frances R. Balkwill, Alberto Mantovani · The Lancet Feb 2001 7,766
5 Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Andrew Rhodes et al. · Intensive Care Medicine Open access 18 Jan 2017 6,868
6 The socio-economic implications of the coronavirus pandemic (COVID-19): A review Maria Nicola, Zaid Alsafi, Catrin Sohrabi et al. · International Journal of Surgery Open access 16 Apr 2020 6,554
7 World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) Catrin Sohrabi, Zaid Alsafi, Niamh O’Neill et al. · International Journal of Surgery Open access 26 Feb 2020 6,329
8 The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines Riaz Agha et al. · International Journal of Surgery Open access 9 Nov 2020 5,605
9 MEASUREMENT OF PAIN E.C. HUSKISSON · The Lancet Nov 1974 4,523
10 The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms Rita Alaggio et al. · Leukemia Open access 22 Jun 2022 4,010
11 Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial Jonathan E. Rosenberg et al. · The Lancet Open access 5 Mar 2016 3,762
12 J Antimicrob Chemother 1994; 33: 350–351 Elizabeth M. O’Shaughnessy, SATYA S. DAS · Journal of Antimicrobial Chemotherapy 1994 3,753
13 Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma Brian I. Rini et al. · New England Journal of Medicine Open access 16 Feb 2019 3,488
14 EAU Guidelines on Renal Cell Carcinoma: 2014 Update Börje Ljungberg, Karim Bensalah, Steven E. Canfield et al. · European Urology Open access 21 Jan 2015 3,474
15 DNA methylation-based classification of central nervous system tumours David Capper et al. · Nature Open access143 authors 13 Mar 2018 3,228
16 Effects of Torcetrapib in Patients at High Risk for Coronary Events Philip J. Barter, Mark J. Caulfield, Mats A. L. Eriksson et al. · New England Journal of Medicine Open access 5 Nov 2007 3,168
17 Wireless capsule endoscopy Gavriel J. Iddan, Gavriel Meron, Arkady Glukhovsky et al. · Nature 25 May 2000 3,074
18 Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease Janine Bestall, ELIZABETH A. PAUL, R. Garrod et al. · Thorax Open access Jul 1999 2,976
19 Controlled Sedation with Alphaxalone-Alphadolone Michael A. E. Ramsay, T.M. Savege, B. R. J. Simpson et al. · BMJ Open access 22 Jun 1974 2,925
20 Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy Matthew J. Maurer et al. · New England Journal of Medicine Open access 27 Aug 2018 2,841
21 Graphic representation of pain Jane Scott, E.C. HUSKISSON · Pain Jun 1976 2,730
22 Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 Christina Fitzmaurice et al. · JAMA Oncology Open access628 authors 27 Sep 2019 2,699
23 Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma Paul Gerard Guy Richardson et al. · New England Journal of Medicine Open access 15 Jun 2005 2,514
24 Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning Margaret Ann Shipp, Ken N. Ross, Pablo Tamayo et al. · Nature Medicine 2002 2,460
25 Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis John Allotey et al. · BMJ ReviewOpen access Sep 2020 2,402
26 British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults Christopher Andrew Lamb et al. · Gut Open access 27 Sep 2019 2,370
27 Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease TERENCE A. R. SEEMUNGAL, Gavin C. Donaldson, ELIZABETH A. PAUL et al. · American Journal of Respiratory and Critical Care Medicine May 1998 2,344
28 The SCARE 2018 statement: Updating consensus Surgical CAse REport (SCARE) guidelines Riaz Agha et al. · International Journal of Surgery Open access 18 Oct 2018 2,340
29 Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease Gavin C. Donaldson · Thorax Open access 25 Sep 2002 2,304
30 Listening to silence and understanding nonsense: exonic mutations that affect splicing Luca Cartegni, Shern L. Chew, Adrian R. Krainer · Nature Reviews Genetics Review Apr 2002 2,237
31 Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial Arjun Vasant Balar et al. · The Lancet Open access 7 Dec 2016 2,230
32 Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022 John Patrick Thornhill et al. · New England Journal of Medicine Open access 21 Jul 2022 2,219
33 Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults Chris Frerk, Viki Mitchell, Alistair F. McNarry et al. · British Journal of Anaesthesia Open access 10 Nov 2015 2,218
34 Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes Eleftheria Zeggini et al. · Science Open access 26 Apr 2007 2,218
35 Multiple sclerosis – a review Ruth Dobson, Gavin Giovannoni · European Journal of Neurology Open access 10 Oct 2018 2,167
36 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management Fernando Gomollón et al. · Journal of Crohn s and Colitis Open access 22 Sep 2016 2,100
37 Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials David J. Grimwade, Robert K. Hills, Anthony V. Moorman et al. · Blood Open access 12 Apr 2010 1,972
38 Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial Sheena McCormack et al. · The Lancet Open access 11 Sep 2015 1,919
39 Regulatory Functions of the Vascular Endothelium Franklin H. Epstein, John Robert Vane, Erik Änggård et al. · New England Journal of Medicine 5 Jul 1990 1,902
40 A simple method of reducing the fading of immunofluorescence during microscopy G. Dana Johnson, Gloria M. de C. Nogueira Araujo · Journal of Immunological Methods Jun 1981 1,886
41 Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes Eleftheria Zeggini et al. · Nature Genetics ReviewOpen access 30 Mar 2008 1,880
42 Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer Hans von der Maase, Lisa Sengeløv, James T. Roberts et al. · Journal of Clinical Oncology 20 Jul 2005 1,870
43 ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications Christian Maaser et al. · Journal of Crohn s and Colitis Open access 17 Aug 2018 1,868
44 Stromal Gene Signatures in Large-B-Cell Lymphomas Georg Lenz et al. · New England Journal of Medicine Open access 26 Nov 2008 1,851
45 beta-Lactamases in laboratory and clinical resistance David M. Livermore · Clinical Microbiology Reviews Open access Oct 1995 1,744
46 Acute Traumatic Coagulopathy Karim Brohi, Jasmin Singh, Mischa Heron et al. · The Journal of Trauma: Injury, Infection, and Critical Care Jun 2003 1,737
47 Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial Robert Louis Coleman et al. · The Lancet Open access117 authors 12 Sep 2017 1,729
48 Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Jane A. Mitchell, Pravit Akarasereenont, Christoph Thiemermann et al. · Proceedings of the National Academy of Sciences Open access 15 Dec 1993 1,671
49 A classification of fistula-in-ano Alan G Parks, P H Gordon, J D Hardcastle · British journal of surgery 1976 1,665
50 Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. Tim A. Lister, D. Crowther, S.B. Sutcliffe et al. · Journal of Clinical Oncology Nov 1989 1,640

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.